PDLIM2 loss in the epithelium impairs antioxidant responses and adhesion signals preceding the development of ulcerative colitis
Download from source ↗Dataset overview
Loss of the PDLIM2 protein during chronic colitis promotes inflammation, impaired epithelium recovery, alterations to the microbiome and oxidative stress.
Abstract
<h4>Introduction</h4>Ulcerative colitis (UC) involves impaired wound healing processes contributing to sustained immune and microbial interactions that aggravate intestinal injury and may progress to colitis-associated cancer (CAC). Here we investigated whether PDLIM2, a known regulator of both epithelial and immune cell fate, contributes to colitis progression.<h4>Methods</h4>PDLIM2 knockout mice (-/-) and wildtype littermates (+/+) were assessed for responses to dextran sodium sulphate (DSS)-induced colitis, and to aoxymethane +DSS. Microbiota were assessed using 16s rRNA amplicon sequencing. Mechanistic studies were carried out in Caco-2 cell cultures, and in silico analysis was carried out on single cell RNA sequencing data from patients with Ulcerative colitis or Crohn's disease.<h4>Results and discussion</h4>Compared to PDLIM2 +/+ mice, PDLIM2 -/- mice exhibited exacerbated and unresolved epithelial damage and inflammation accompanied by immune cell infiltration, which was precluded sufficient time to observe tunour development. PDLIM2 -/- mice exhibited altered basal gut microbial diversity, composition and predicted functionality compared to +/+ mice. Interestingly, in +/+ mice, PDLIM2 expression was lost over the course of DSS-induced colitis. Mechanistic studies in Caco-2 enterocyte cell cultures demonstrated that PDLIM2 suppression resulted in impaired cell adhesion signalling and sustained oxidative stress. In silico analysis of single cell RNA seq data sets from patients with ulcerative colitis and Crohn's disease demonstrated that although PDLIM2 was clearly expressed in normal human colonic epithelial enterocyte populations, its expression declined in both ulcerative colitis and Crohn's disease. We conclude that PDLIM2 is necessary for intestinal homeostasis through regulation of cell adhesion and antioxidant pathways, while loss of PDLIM2 sustains inflammation and epithelial damage.
doi:10.3389/fendo.2025.1720162 ↗ PMID 41743827 ↗ PMC12929155 ↗
Study facts
- Organism
- —
- Platform
- Illumina MiSeq
- Age group
- —
- Disease groups
- —
- Anatomical sites
- —
Data availability
Specific data assets have not been resolved from the source yet — see the source repository below for the full file listing.
Strengths & limitations for reuse
Strengths
- Raw reads are advertised
- Taxonomic tables are advertised
- Sample counts are documented
Limitations
- Not documented: feature/otu tables are advertised
- Not documented: participant counts are documented
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.paired_end |
True |
Sequencing was performed on an Illumina MiSeq platform using a 2 × 250 bp paired-end protocol Section |
assay.platform |
Illumina MiSeq from source |
ENA instrument_model=Illumina MiSeq Section |
assay.primers_reported |
True |
using the 341F and 785R primers containing Illumina adapter overhang sequences Section |
assay.read_depth_reported |
345377 |
yielding 345,377 high-quality reads (mean ± SEM, 15,699 ± 2,546) Section |
assay.read_length |
250 |
using a 2 × 250 bp paired-end protocol Section |
assay.sequencing_type |
amplicon_16s |
Samples were processed by 16S rRNA amplicon sequencing Section |
assay.target_region |
V3–V4 |
the V3–V4 hypervariable region of the 16S rRNA gene was amplified using the 341F and 785R primers Section |
Cohort
| Field | Value | Evidence |
|---|---|---|
cohort.disease_activity_metadata_available |
True |
Daily disease activity index (DDAI) incorporating stool consistency, fur texture, animal posture, and body weight change was assessed Section |
cohort.treatment_exposure_documented |
True |
6 for untreated control PDLIM2 +/+ mice, 7 for DSS-treated PDLIM2 +/+, 4 for untreated PDLIM2 -/- and 5 for DSS-treated PDLIM2 -/- Section |
cohort.treatment_response_metadata_available |
True |
PDLIM2 absence and DSS treatment similarly affected the dominant fraction of the microbial ecosystem. Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.raw_reads |
True |
Sequencing reads were deposited in the National Center for Biotechnology Information Sequence Read Archive (NCBI SRA; BioProject: PRJNA1192040). Section |
data_assets.taxonomic_table |
True inferred |
The latter decreased in PDLIM2 -/- DSS mice compared to PDLIM2 -/- and PDLIM2 +/+ control mice ... Supplementary Table 1 Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.body_site |
gut |
we next compared the gut microbiota profile in these mice to their PDLIM2 +/+ counterparts Section |
specimens.inflamed_status_available |
True |
6 for untreated control PDLIM2 +/+ mice, 7 for DSS-treated PDLIM2 +/+, 4 for untreated PDLIM2 -/- and 5 for DSS-treated PDLIM2 -/- Section |
specimens.longitudinal_sampling |
False inferred |
Stool sampling was performed on the day of culling Section |
specimens.number_of_samples |
22 from source |
ENA sample_count=22 Section |
specimens.sample_type |
stool |
Stool sampling was performed on the day of culling for a total of 22 samples Section |